<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30081349</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>09</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>09</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-376X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>1095</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>15</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</Title>                <ISOAbbreviation>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.</ISOAbbreviation>            </Journal>            <ArticleTitle>FPSE-HPLC-DAD method for the quantification of anticancer drugs in human whole blood, plasma, and urine.</ArticleTitle>            <Pagination>                <MedlinePgn>204-213</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1570-0232(18)30816-X</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jchromb.2018.07.042</ELocationID>            <Abstract>                <AbstractText>The present work describes a fast, sensitive and selective procedure for the analyses of aromatase inhibitors including anastrozole, letrozole and exemestane used in the treatment of metastatic breast cancer by high performance liquid chromatography (HPLC) in human whole blood, plasma, and urine samples succeeding an extraction by innovative fabric phase sorptive extraction (FPSE). These drugs were successfully determined using a Luna C<sub>18</sub> column at 25 °C using acetonitrile and phosphate buffer. The analytical method was validated, using weighted-matrix matched standard calibration curves. The intra- and inter-day accuracy values (precision and trueness) fulfill the criteria of International Guidelines on Bioanalytical Methods Validation. The analytical performances were further tested on real human biological samples. To the best of our knowledge, this is the first FPSE procedure applied to human whole blood, plasma, and urine samples for the concurrent analysis of aromatase inhibitors possessing a wide range of polarity index values and could be easily adopted as a rapid and green analytical protocol for clinical and pharmaceutical applications. The proposed HPLC method is very innovative since in the literature there are only methods dealing with a single antitumoral drug, and no process has been described so far for these three antitumoral drugs together directly from the whole blood.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Locatelli</LastName>                    <ForeName>Marcello</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy. Electronic address: m.locatelli@unich.it.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tinari</LastName>                    <ForeName>Nicola</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale - CeSI-MeT, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Grassadonia</LastName>                    <ForeName>Antonino</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Medical, Oral and Biotechnological Sciences, Centro Scienze dell'Invecchiamento e Medicina Traslazionale - CeSI-MeT, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tartaglia</LastName>                    <ForeName>Angela</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Macerola</LastName>                    <ForeName>Daniela</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Piccolantonio</LastName>                    <ForeName>Silvia</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sperandio</LastName>                    <ForeName>Elena</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>D'Ovidio</LastName>                    <ForeName>Cristian</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Section of Legal Medicine, Department of Medicine and Aging Sciences, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Carradori</LastName>                    <ForeName>Simone</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>University of Chieti - Pescara &quot;G. d'Annunzio&quot;, Department of Pharmacy, Chieti, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ulusoy</LastName>                    <ForeName>Halil Ibrahim</ForeName>                    <Initials>HI</Initials>                    <AffiliationInfo>                        <Affiliation>Cumhuriyet University, Faculty of Pharmacy, Department of Analytical Chemistry, Sivas, Turkey.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Furton</LastName>                    <ForeName>Kenneth G</ForeName>                    <Initials>KG</Initials>                    <AffiliationInfo>                        <Affiliation>International Forensic Research Institute, Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kabir</LastName>                    <ForeName>Abuzar</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>International Forensic Research Institute, Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA. Electronic address: akabir@fiu.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>31</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>J Chromatogr B Analyt Technol Biomed Life Sci</MedlineTA>            <NlmUniqueID>101139554</NlmUniqueID>            <ISSNLinking>1570-0232</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>                <QualifierName UI="Q000652" MajorTopicYN="Y">urine</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D057230" MajorTopicYN="N">Limit of Detection</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Anastrozole</Keyword>            <Keyword MajorTopicYN="N">Antitumoral drug</Keyword>            <Keyword MajorTopicYN="N">Exemestane</Keyword>            <Keyword MajorTopicYN="N">Extraction procedure</Keyword>            <Keyword MajorTopicYN="N">FPSE-HPLC-DAD</Keyword>            <Keyword MajorTopicYN="N">Letrozole</Keyword>            <Keyword MajorTopicYN="N">Method validation</Keyword>            <Keyword MajorTopicYN="N">Whole blood, plasma and urine</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30081349</ArticleId>            <ArticleId IdType="pii">S1570-0232(18)30816-X</ArticleId>            <ArticleId IdType="doi">10.1016/j.jchromb.2018.07.042</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>